Burning Rock Biotech Limited announced unaudited consolidated financial results for the fourth quarter and full year ended December 31, 2020. For the quarter, the company reported revenues of RMB 131,722,000 against RMB 88,675,000 a year ago. Loss from operations was RMB 155,373,000 against RMB 95,483,000 a year ago. Net loss was RMB 127,130,000 against RMB 32,167,000 a year ago. For the full year, the company reported revenues of RMB 429,903,000 against RMB 381,677,000 a year ago. Loss from operations was RMB 412,405,000 against RMB 169,092,000 a year ago. Net loss was RMB 407,235,000 against RMB 169,156,000 a year ago.